Sydney, Jan 23, 2008 (ABN Newswire) - SciGen Limited (ASX: SIE) announces that it has been awarded the GMP certification of its manufacturing facility in Rehovot, Israel where its third generation hepatitis B vaccine Sci B Vac is manufactured. This comes after having successfully implemented and complied with all the requirements as specified by the World Health Organisation (WHO) and the Ministry of Health of Israel.